Replies to post #99095 on Biotech Values

[rwwine]

IDIX

Was the Stifel Nicolaus report a re-issue from earlier this year from Thomas Weisel? If not were there any changes or updates you can share? TIA

Regards

[rwwine]

Do you see IDIX being acquired then in the next 5 years assuming their pipeline of HCV drugs continue to demonstrate significant efficacy? TIA.

It doesn't seem to me that the IDX 899 compound is considered and or appreciated by those covering IDIX when it comes to valuation. JMHO